Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011

Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011–2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshaghi, AliReza, Memari, Nader, Tang, Patrick, Olsha, Romy, Farrell, David J., Low, Donald E., Gubbay, Jonathan B., Patel, Samir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2013
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810904/
https://www.ncbi.nlm.nih.gov/pubmed/23968896
http://dx.doi.org/10.3201/eid1909.121466
Descripción
Sumario:Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011–2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.

Ejemplares similares